MacroGenics, Inc.
MGNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 227.5% | 68.6% | -25.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 81.6% | 60% | 59.1% | 69% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 30.1% | -150.3% | -297% | -70.2% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 23.1% | -163% | -311.1% | -87% |
| EPS Diluted | 0.27 | -0.57 | -0.65 | -0.25 |
| % Growth | 147.4% | 12.3% | -160% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |